Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Omega Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 44 | 49 | +5 |
| Shares | 42.6M | 42.7M | +66.1K (+0.2%) |
| Value | $230.9M | $389.2M | +$158.3M (+68.6%) |
New holders (7)
Institutions that held Omega Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 27,301 | $155.9K | 0.01% |
| Dimensional Fund Advisors LP | 19,126 | $109.0K | 0.00% |
| Bank of New York Mellon Corp | 17,522 | $100.0K | 0.00% |
| Boothbay Fund Management, LLC | 16,683 | $95.3K | 0.00% |
| Man Group plc | 16,409 | $93.7K | 0.00% |
| Jefferies Financial Group Inc. | 7,725 | $44.1K | 0.00% |
| Lazard Asset Management LLC | 1,339 | $7.00K | 0.00% |
Sold out (2)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Occudo Quantitative Strategies LP | 11,534 | $63.0K |
| LPL Financial LLC | 10,392 | $56.0K |